Aytu BioPharma (NASDAQ:AYTU) Announces Earnings Results, Misses Estimates By $0.37 EPS
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) announced its earnings results on Thursday. The company reported ($0.82) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.37), Zacks reports. Aytu BioPharma had a negative net margin of 14.60% and a negative return on equity of 31.31%. The business had revenue of […]
More Stories
Ukraine: UN official deplores deadly double attack on hospital
The top UN aid official in Ukraine has condemned Russian attacks in the northeastern city of Sumy on Saturday which...
CEMEX, S.A.B. de C.V. (NYSE:CX) Receives Average Rating of “Moderate Buy” from Analysts
Shares of CEMEX, S.A.B. de C.V. (NYSE:CX – Get Free Report) have been assigned an average recommendation of “Moderate Buy”...
Shell plc (NYSE:SHEL) Given Average Rating of “Moderate Buy” by Brokerages
Shell plc (NYSE:SHEL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven brokerages that...
Premium Brands Holdings Co. (TSE:PBH) Given Average Rating of “Moderate Buy” by Brokerages
Premium Brands Holdings Co. (TSE:PBH – Get Free Report) has received a consensus rating of “Moderate Buy” from the nine...
Nearly 50 Percent of US Homes Remain Unsold for at Least 60 Days: Report
By Naveen Athrappully Almost half of all homes remain unsold for at least 60 days, according to real estate brokerage...
Short Interest in VanEck Digital Transformation ETF (NASDAQ:DAPP) Rises By 129.7%
VanEck Digital Transformation ETF (NASDAQ:DAPP – Get Free Report) was the recipient of a significant increase in short interest during...